Dimetyylitryptamiini (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dimetyylitryptamiini" in Finnish language version.

refsWebsite

Global rank Finnish rank

26nih.gov

4^th place

12^th place

25doi.org

2^nd place

10^th place

25worldcat.org

5^th place

9^th place

4sciencedirect.com

149^th place

237^th place

4researchgate.net

120^th place

243^rd place

3finlex.fi

3,070^th place

17^th place

3wiley.com

222^nd place

202^nd place

2sagepub.com

731^st place

767^th place

2springer.com

274^th place

418^th place

1mdpi.com

2,912^th place

2,125^th place

1akjournals.com

low place

1therooster.com

low place

9,014^th place

1web.archive.org

1^st place

1maps.org

low place

5,059^th place

1slub-dresden.de

low place

1archive.org

6^th place

164^th place

1nrcresearchpress.com

low place

5,096^th place

1sciencemag.org

857^th place

545^th place

1yle.fi

380^th place

2^nd place

akjournals.com

GN Rossi et al: Internet method for the extraction of N,N -dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine? Journal of Psychedelic Studies, 2019, nro 1, s. 1–6. doi:10.1556/2054.2019.009 ISSN 2559-9283 Artikkelin verkkoversio.

archive.org

M Villavicencio: Geografia de la Republica del Ecuador, s. 373. Robert Graighead, 1858. OCLC: 66589380 Teoksen verkkoversio.

doi.org

dx.doi.org

AM Brito-da-Costa et al: Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact. Pharmaceuticals, 2020, 13. vsk, nro 11, s. 334. doi:10.3390/ph13110334 Artikkelin verkkoversio.
A Gaujac et al: Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry. Microchemical Journal, 2013, 110. vsk, s. 146–157. doi:10.1016/j.microc.2013.03.009 ISSN 0026-265X Artikkelin verkkoversio.
SA Barker: N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine Its role and function. Frontiers in Neuroscience, 2018, 12. vsk. PubMed:30127713 doi:10.3389/fnins.2018.00536 ISSN 1662-4548 Artikkelin verkkoversio.
J Riba et al: Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing and Analysis, 2012, 4. vsk, nro 7-8, s. 610–616. PubMed:22514127 doi:10.1002/dta.1344 ISSN 1942-7611 Artikkelin verkkoversio.
J Hamill et al: Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 2019, 17. vsk, nro 2, s. 108–128. PubMed:29366418 doi:10.2174/1570159X16666180125095902 ISSN 1570-159X Artikkelin verkkoversio.
TM Carbonaro, MB Gatch: Neuropharmacology of N,N-dimethyltryptamine. Brain research bulletin, 2016, 126. vsk, nro Pt 1, s. 74–88. PubMed:27126737 doi:10.1016/j.brainresbull.2016.04.016 ISSN 0361-9230 Artikkelin verkkoversio.
DE Nichols: N,N-dimethyltryptamine and the pineal gland: separating fact from myth. Journal of Psychopharmacology, 2018, 32. vsk, nro 1, s. 30–36. PubMed:29095071 doi:10.1177/0269881117736919 ISSN 1461-7285 Artikkelin verkkoversio.
AR Winstock, S Kaar, R Borschmann: Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology, 2014, 28. vsk, nro 1, s. 49–54. PubMed:24284475 doi:10.1177/0269881113513852 ISSN 1461-7285 Artikkelin verkkoversio.
MJ Miller et al: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116. vsk, nro 23, s. 11207–11212. PubMed:31061128 doi:10.1073/pnas.1902174116 ISSN 0027-8424 Artikkelin verkkoversio.
GN Rossi et al: Internet method for the extraction of N,N -dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine? Journal of Psychedelic Studies, 2019, nro 1, s. 1–6. doi:10.1556/2054.2019.009 ISSN 2559-9283 Artikkelin verkkoversio.
V Cakic, J Potkonyak, A Marshall: Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug and Alcohol Dependence, 2010, 111. vsk, nro 1, s. 30–37. PubMed:20570058 doi:10.1016/j.drugalcdep.2010.03.015 ISSN 0376-8716 Artikkelin verkkoversio.
NV Cozzi, PF Daley: Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials. Drug Testing and Analysis, 2020, 12. vsk, nro 10, s. 1483–1493. PubMed:32608093 doi:10.1002/dta.2889 ISSN 1942-7611 Artikkelin verkkoversio.
RS Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction, 2007, 102. vsk, nro 1, s. 24–34. PubMed:17207120 doi:10.1111/j.1360-0443.2006.01652.x ISSN 0965-2140 Artikkelin verkkoversio.
PA de Smet: A multidisciplinary overview of intoxicating enema rituals in the western hemisphere. Journal of Ethnopharmacology, 1983, 9. vsk, nro 2-3, s. 129–166. PubMed:6677814 doi:10.1016/0378-8741(83)90031-4 ISSN 0378-8741 Artikkelin verkkoversio.
RJ Strassman et al: Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry, 1994, 51. vsk, nro 2, s. 98–108. PubMed:8297217 doi:10.1001/archpsyc.1994.03950020022002 ISSN 0003-990X Artikkelin verkkoversio.
AK Davis et al: Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology, 2020, 34. vsk, nro 9, s. 1008–1020. PubMed:32345112 doi:10.1177/0269881120916143 ISSN 0269-8811 Artikkelin verkkoversio.
RJ Strassman, CR Qualls, LM Berg: Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biological Psychiatry, 1996, 39. vsk, nro 9, s. 784–795. PubMed:8731519 doi:10.1016/0006-3223(95)00200-6 ISSN 0006-3223 Artikkelin verkkoversio.
DE Rosenberg et al: The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia, 1964, 5. vsk, s. 217–227. PubMed:14138757 doi:10.1007/BF00413244 Artikkelin verkkoversio.
AY Simão et al: Toxicological aspects and determination of the main components of ayahuasca: a critical review. Medicines, 2019, 6. vsk, nro 4. PubMed:31635364 doi:10.3390/medicines6040106 ISSN 2305-6320 Artikkelin verkkoversio.
JL Hagman, GC Marten, AW Hovin: Alkaloid concentration in plant parts of reed canarygrass of varying maturity. Crop Science, 1975, 15. vsk, nro 1, s. 41–43. doi:10.2135/cropsci1975.0011183X001500010012x ISSN 1435-0653 Artikkelin verkkoversio.^{[vanhentunut linkki]}
JG Dean et al: Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Scientific Reports, 2019, 9. vsk, nro 1, s. 93–33. PubMed:31249368 doi:10.1038/s41598-019-45812-w ISSN 2045-2322 Artikkelin verkkoversio.
BR Sitaram et al: In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochemical Pharmacology, 1987, 36. vsk, nro 9, s. 1509–1512. PubMed:3472526 doi:10.1016/0006-2952(87)90118-3 ISSN 0006-2952 Artikkelin verkkoversio.
RFH Manske: A synthesis of the methyltryptamines and some derivatives. Canadian Journal of Research, 1931, 5. vsk, nro 5, s. 592–600. doi:10.1139/cjr31-097 ISSN 1923-4287 Artikkelin verkkoversio.
S Szára: Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia, 1956, 12. vsk, nro 11, s. 441–442. PubMed:13384414 doi:10.1007/BF02157378 ISSN 1420-9071 Artikkelin verkkoversio.
J Axelrod: Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science, 1961, 134. vsk, nro 3475, s. 343. PubMed:13685339 doi:10.1126/science.134.3475.343 ISSN 0036-8075 Artikkelin verkkoversio.

finlex.fi

Valtioneuvoston asetus huumausaineina… 543/2008 finlex.fi. Viitattu 7.12.2017.
Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta (201/2016). Oikeusministeriö, 2019. ISSN 1455-8904 Artikkelin verkkoversio.
Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta (415/2019). Oikeusministeriö, 2019. ISSN 1455-8904 Artikkelin verkkoversio.

maps.org

RJ Strassman, CR Qualls, LM Berg: Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biological Psychiatry, 1996, 39. vsk, nro 9, s. 784–795. PubMed:8731519 doi:10.1016/0006-3223(95)00200-6 ISSN 0006-3223 Artikkelin verkkoversio.

mdpi.com

AM Brito-da-Costa et al: Toxicokinetics and toxicodynamics of ayahuasca alkaloids N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact. Pharmaceuticals, 2020, 13. vsk, nro 11, s. 334. doi:10.3390/ph13110334 Artikkelin verkkoversio.

nih.gov

pubmed.ncbi.nlm.nih.gov

SA Barker: N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine Its role and function. Frontiers in Neuroscience, 2018, 12. vsk. PubMed:30127713 doi:10.3389/fnins.2018.00536 ISSN 1662-4548 Artikkelin verkkoversio.
J Riba et al: Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing and Analysis, 2012, 4. vsk, nro 7-8, s. 610–616. PubMed:22514127 doi:10.1002/dta.1344 ISSN 1942-7611 Artikkelin verkkoversio.
J Hamill et al: Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 2019, 17. vsk, nro 2, s. 108–128. PubMed:29366418 doi:10.2174/1570159X16666180125095902 ISSN 1570-159X Artikkelin verkkoversio.
TM Carbonaro, MB Gatch: Neuropharmacology of N,N-dimethyltryptamine. Brain research bulletin, 2016, 126. vsk, nro Pt 1, s. 74–88. PubMed:27126737 doi:10.1016/j.brainresbull.2016.04.016 ISSN 0361-9230 Artikkelin verkkoversio.
DE Nichols: N,N-dimethyltryptamine and the pineal gland: separating fact from myth. Journal of Psychopharmacology, 2018, 32. vsk, nro 1, s. 30–36. PubMed:29095071 doi:10.1177/0269881117736919 ISSN 1461-7285 Artikkelin verkkoversio.
AR Winstock, S Kaar, R Borschmann: Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology, 2014, 28. vsk, nro 1, s. 49–54. PubMed:24284475 doi:10.1177/0269881113513852 ISSN 1461-7285 Artikkelin verkkoversio.
MJ Miller et al: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116. vsk, nro 23, s. 11207–11212. PubMed:31061128 doi:10.1073/pnas.1902174116 ISSN 0027-8424 Artikkelin verkkoversio.
V Cakic, J Potkonyak, A Marshall: Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug and Alcohol Dependence, 2010, 111. vsk, nro 1, s. 30–37. PubMed:20570058 doi:10.1016/j.drugalcdep.2010.03.015 ISSN 0376-8716 Artikkelin verkkoversio.
NV Cozzi, PF Daley: Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials. Drug Testing and Analysis, 2020, 12. vsk, nro 10, s. 1483–1493. PubMed:32608093 doi:10.1002/dta.2889 ISSN 1942-7611 Artikkelin verkkoversio.
RS Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction, 2007, 102. vsk, nro 1, s. 24–34. PubMed:17207120 doi:10.1111/j.1360-0443.2006.01652.x ISSN 0965-2140 Artikkelin verkkoversio.
PA de Smet: A multidisciplinary overview of intoxicating enema rituals in the western hemisphere. Journal of Ethnopharmacology, 1983, 9. vsk, nro 2-3, s. 129–166. PubMed:6677814 doi:10.1016/0378-8741(83)90031-4 ISSN 0378-8741 Artikkelin verkkoversio.
RJ Strassman et al: Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry, 1994, 51. vsk, nro 2, s. 98–108. PubMed:8297217 doi:10.1001/archpsyc.1994.03950020022002 ISSN 0003-990X Artikkelin verkkoversio.
AK Davis et al: Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology, 2020, 34. vsk, nro 9, s. 1008–1020. PubMed:32345112 doi:10.1177/0269881120916143 ISSN 0269-8811 Artikkelin verkkoversio.
RJ Strassman, CR Qualls, LM Berg: Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biological Psychiatry, 1996, 39. vsk, nro 9, s. 784–795. PubMed:8731519 doi:10.1016/0006-3223(95)00200-6 ISSN 0006-3223 Artikkelin verkkoversio.
DE Rosenberg et al: The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia, 1964, 5. vsk, s. 217–227. PubMed:14138757 doi:10.1007/BF00413244 Artikkelin verkkoversio.
AY Simão et al: Toxicological aspects and determination of the main components of ayahuasca: a critical review. Medicines, 2019, 6. vsk, nro 4. PubMed:31635364 doi:10.3390/medicines6040106 ISSN 2305-6320 Artikkelin verkkoversio.
JG Dean et al: Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Scientific Reports, 2019, 9. vsk, nro 1, s. 93–33. PubMed:31249368 doi:10.1038/s41598-019-45812-w ISSN 2045-2322 Artikkelin verkkoversio.
BR Sitaram et al: In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochemical Pharmacology, 1987, 36. vsk, nro 9, s. 1509–1512. PubMed:3472526 doi:10.1016/0006-2952(87)90118-3 ISSN 0006-2952 Artikkelin verkkoversio.
S Szára: Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia, 1956, 12. vsk, nro 11, s. 441–442. PubMed:13384414 doi:10.1007/BF02157378 ISSN 1420-9071 Artikkelin verkkoversio.
J Axelrod: Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science, 1961, 134. vsk, nro 3475, s. 343. PubMed:13685339 doi:10.1126/science.134.3475.343 ISSN 0036-8075 Artikkelin verkkoversio.

ncbi.nlm.nih.gov

SA Barker: N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine Its role and function. Frontiers in Neuroscience, 2018, 12. vsk. PubMed:30127713 doi:10.3389/fnins.2018.00536 ISSN 1662-4548 Artikkelin verkkoversio.
J Hamill et al: Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 2019, 17. vsk, nro 2, s. 108–128. PubMed:29366418 doi:10.2174/1570159X16666180125095902 ISSN 1570-159X Artikkelin verkkoversio.
TM Carbonaro, MB Gatch: Neuropharmacology of N,N-dimethyltryptamine. Brain research bulletin, 2016, 126. vsk, nro Pt 1, s. 74–88. PubMed:27126737 doi:10.1016/j.brainresbull.2016.04.016 ISSN 0361-9230 Artikkelin verkkoversio.
MJ Miller et al: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116. vsk, nro 23, s. 11207–11212. PubMed:31061128 doi:10.1073/pnas.1902174116 ISSN 0027-8424 Artikkelin verkkoversio.
AY Simão et al: Toxicological aspects and determination of the main components of ayahuasca: a critical review. Medicines, 2019, 6. vsk, nro 4. PubMed:31635364 doi:10.3390/medicines6040106 ISSN 2305-6320 Artikkelin verkkoversio.
JG Dean et al: Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Scientific Reports, 2019, 9. vsk, nro 1, s. 93–33. PubMed:31249368 doi:10.1038/s41598-019-45812-w ISSN 2045-2322 Artikkelin verkkoversio.

nrcresearchpress.com

RFH Manske: A synthesis of the methyltryptamines and some derivatives. Canadian Journal of Research, 1931, 5. vsk, nro 5, s. 592–600. doi:10.1139/cjr31-097 ISSN 1923-4287 Artikkelin verkkoversio.

researchgate.net

AR Winstock, S Kaar, R Borschmann: Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology, 2014, 28. vsk, nro 1, s. 49–54. PubMed:24284475 doi:10.1177/0269881113513852 ISSN 1461-7285 Artikkelin verkkoversio.
RS Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction, 2007, 102. vsk, nro 1, s. 24–34. PubMed:17207120 doi:10.1111/j.1360-0443.2006.01652.x ISSN 0965-2140 Artikkelin verkkoversio.
BC Labate et al: The world Ayahuasca diaspora: reinventions and controversies, s. 152–154. Routledge, 2017. ISBN 9781472466631 Teoksen verkkoversio.
RJ Strassman et al: Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry, 1994, 51. vsk, nro 2, s. 98–108. PubMed:8297217 doi:10.1001/archpsyc.1994.03950020022002 ISSN 0003-990X Artikkelin verkkoversio.

sagepub.com

journals.sagepub.com

DE Nichols: N,N-dimethyltryptamine and the pineal gland: separating fact from myth. Journal of Psychopharmacology, 2018, 32. vsk, nro 1, s. 30–36. PubMed:29095071 doi:10.1177/0269881117736919 ISSN 1461-7285 Artikkelin verkkoversio.
AK Davis et al: Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology, 2020, 34. vsk, nro 9, s. 1008–1020. PubMed:32345112 doi:10.1177/0269881120916143 ISSN 0269-8811 Artikkelin verkkoversio.

sciencedirect.com

A Gaujac et al: Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry. Microchemical Journal, 2013, 110. vsk, s. 146–157. doi:10.1016/j.microc.2013.03.009 ISSN 0026-265X Artikkelin verkkoversio.
V Cakic, J Potkonyak, A Marshall: Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug and Alcohol Dependence, 2010, 111. vsk, nro 1, s. 30–37. PubMed:20570058 doi:10.1016/j.drugalcdep.2010.03.015 ISSN 0376-8716 Artikkelin verkkoversio.
PA de Smet: A multidisciplinary overview of intoxicating enema rituals in the western hemisphere. Journal of Ethnopharmacology, 1983, 9. vsk, nro 2-3, s. 129–166. PubMed:6677814 doi:10.1016/0378-8741(83)90031-4 ISSN 0378-8741 Artikkelin verkkoversio.
BR Sitaram et al: In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochemical Pharmacology, 1987, 36. vsk, nro 9, s. 1509–1512. PubMed:3472526 doi:10.1016/0006-2952(87)90118-3 ISSN 0006-2952 Artikkelin verkkoversio.

sciencemag.org

science.sciencemag.org

J Axelrod: Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science, 1961, 134. vsk, nro 3475, s. 343. PubMed:13685339 doi:10.1126/science.134.3475.343 ISSN 0036-8075 Artikkelin verkkoversio.

slub-dresden.de

digital.slub-dresden.de

FX Veigl: Vormaliger mißionar der gesellschaft Jesu. Gründliche nachrichten über die verfassung der landschaft von maynas in Süd-Amerika bis zum jahre 1768, s. 189. Nürnberg, Saksa: Zeh, 1798. Teoksen verkkoversio.

springer.com

link.springer.com

DE Rosenberg et al: The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia, 1964, 5. vsk, s. 217–227. PubMed:14138757 doi:10.1007/BF00413244 Artikkelin verkkoversio.
S Szára: Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia, 1956, 12. vsk, nro 11, s. 441–442. PubMed:13384414 doi:10.1007/BF02157378 ISSN 1420-9071 Artikkelin verkkoversio.

therooster.com

Reilly Capps: DMT vape pens help bring world's strangest drug into everyday life Rooster Magazine. 23.10.2018. Arkistoitu 25.11.2020. Viitattu 21.11.2020.

web.archive.org

Reilly Capps: DMT vape pens help bring world's strangest drug into everyday life Rooster Magazine. 23.10.2018. Arkistoitu 25.11.2020. Viitattu 21.11.2020.

wiley.com

onlinelibrary.wiley.com

J Riba et al: Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing and Analysis, 2012, 4. vsk, nro 7-8, s. 610–616. PubMed:22514127 doi:10.1002/dta.1344 ISSN 1942-7611 Artikkelin verkkoversio.
NV Cozzi, PF Daley: Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials. Drug Testing and Analysis, 2020, 12. vsk, nro 10, s. 1483–1493. PubMed:32608093 doi:10.1002/dta.2889 ISSN 1942-7611 Artikkelin verkkoversio.

acsess.onlinelibrary.wiley.com

JL Hagman, GC Marten, AW Hovin: Alkaloid concentration in plant parts of reed canarygrass of varying maturity. Crop Science, 1975, 15. vsk, nro 1, s. 41–43. doi:10.2135/cropsci1975.0011183X001500010012x ISSN 1435-0653 Artikkelin verkkoversio.^{[vanhentunut linkki]}

worldcat.org

A Gaujac et al: Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry. Microchemical Journal, 2013, 110. vsk, s. 146–157. doi:10.1016/j.microc.2013.03.009 ISSN 0026-265X Artikkelin verkkoversio.
SA Barker: N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: past, present, and future research to determine Its role and function. Frontiers in Neuroscience, 2018, 12. vsk. PubMed:30127713 doi:10.3389/fnins.2018.00536 ISSN 1662-4548 Artikkelin verkkoversio.
J Riba et al: Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing and Analysis, 2012, 4. vsk, nro 7-8, s. 610–616. PubMed:22514127 doi:10.1002/dta.1344 ISSN 1942-7611 Artikkelin verkkoversio.
J Hamill et al: Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 2019, 17. vsk, nro 2, s. 108–128. PubMed:29366418 doi:10.2174/1570159X16666180125095902 ISSN 1570-159X Artikkelin verkkoversio.
TM Carbonaro, MB Gatch: Neuropharmacology of N,N-dimethyltryptamine. Brain research bulletin, 2016, 126. vsk, nro Pt 1, s. 74–88. PubMed:27126737 doi:10.1016/j.brainresbull.2016.04.016 ISSN 0361-9230 Artikkelin verkkoversio.
DE Nichols: N,N-dimethyltryptamine and the pineal gland: separating fact from myth. Journal of Psychopharmacology, 2018, 32. vsk, nro 1, s. 30–36. PubMed:29095071 doi:10.1177/0269881117736919 ISSN 1461-7285 Artikkelin verkkoversio.
AR Winstock, S Kaar, R Borschmann: Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology, 2014, 28. vsk, nro 1, s. 49–54. PubMed:24284475 doi:10.1177/0269881113513852 ISSN 1461-7285 Artikkelin verkkoversio.
MJ Miller et al: Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116. vsk, nro 23, s. 11207–11212. PubMed:31061128 doi:10.1073/pnas.1902174116 ISSN 0027-8424 Artikkelin verkkoversio.
GN Rossi et al: Internet method for the extraction of N,N -dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine? Journal of Psychedelic Studies, 2019, nro 1, s. 1–6. doi:10.1556/2054.2019.009 ISSN 2559-9283 Artikkelin verkkoversio.
V Cakic, J Potkonyak, A Marshall: Dimethyltryptamine (DMT): subjective effects and patterns of use among Australian recreational users. Drug and Alcohol Dependence, 2010, 111. vsk, nro 1, s. 30–37. PubMed:20570058 doi:10.1016/j.drugalcdep.2010.03.015 ISSN 0376-8716 Artikkelin verkkoversio.
NV Cozzi, PF Daley: Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials. Drug Testing and Analysis, 2020, 12. vsk, nro 10, s. 1483–1493. PubMed:32608093 doi:10.1002/dta.2889 ISSN 1942-7611 Artikkelin verkkoversio.
RS Gable: Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction, 2007, 102. vsk, nro 1, s. 24–34. PubMed:17207120 doi:10.1111/j.1360-0443.2006.01652.x ISSN 0965-2140 Artikkelin verkkoversio.
PA de Smet: A multidisciplinary overview of intoxicating enema rituals in the western hemisphere. Journal of Ethnopharmacology, 1983, 9. vsk, nro 2-3, s. 129–166. PubMed:6677814 doi:10.1016/0378-8741(83)90031-4 ISSN 0378-8741 Artikkelin verkkoversio.
RJ Strassman et al: Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry, 1994, 51. vsk, nro 2, s. 98–108. PubMed:8297217 doi:10.1001/archpsyc.1994.03950020022002 ISSN 0003-990X Artikkelin verkkoversio.
AK Davis et al: Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology, 2020, 34. vsk, nro 9, s. 1008–1020. PubMed:32345112 doi:10.1177/0269881120916143 ISSN 0269-8811 Artikkelin verkkoversio.
RJ Strassman, CR Qualls, LM Berg: Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biological Psychiatry, 1996, 39. vsk, nro 9, s. 784–795. PubMed:8731519 doi:10.1016/0006-3223(95)00200-6 ISSN 0006-3223 Artikkelin verkkoversio.
AY Simão et al: Toxicological aspects and determination of the main components of ayahuasca: a critical review. Medicines, 2019, 6. vsk, nro 4. PubMed:31635364 doi:10.3390/medicines6040106 ISSN 2305-6320 Artikkelin verkkoversio.
JL Hagman, GC Marten, AW Hovin: Alkaloid concentration in plant parts of reed canarygrass of varying maturity. Crop Science, 1975, 15. vsk, nro 1, s. 41–43. doi:10.2135/cropsci1975.0011183X001500010012x ISSN 1435-0653 Artikkelin verkkoversio.^{[vanhentunut linkki]}
JG Dean et al: Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Scientific Reports, 2019, 9. vsk, nro 1, s. 93–33. PubMed:31249368 doi:10.1038/s41598-019-45812-w ISSN 2045-2322 Artikkelin verkkoversio.
BR Sitaram et al: In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochemical Pharmacology, 1987, 36. vsk, nro 9, s. 1509–1512. PubMed:3472526 doi:10.1016/0006-2952(87)90118-3 ISSN 0006-2952 Artikkelin verkkoversio.
RFH Manske: A synthesis of the methyltryptamines and some derivatives. Canadian Journal of Research, 1931, 5. vsk, nro 5, s. 592–600. doi:10.1139/cjr31-097 ISSN 1923-4287 Artikkelin verkkoversio.
S Szára: Dimethyltryptamin: its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia, 1956, 12. vsk, nro 11, s. 441–442. PubMed:13384414 doi:10.1007/BF02157378 ISSN 1420-9071 Artikkelin verkkoversio.
J Axelrod: Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science, 1961, 134. vsk, nro 3475, s. 343. PubMed:13685339 doi:10.1126/science.134.3475.343 ISSN 0036-8075 Artikkelin verkkoversio.
Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta (201/2016). Oikeusministeriö, 2019. ISSN 1455-8904 Artikkelin verkkoversio.
Lääkealan turvallisuus- ja kehittämiskeskuksen päätös lääkeluettelosta (415/2019). Oikeusministeriö, 2019. ISSN 1455-8904 Artikkelin verkkoversio.

yle.fi

Perttu Ruokangas: Netistä tilattu yrtti ei ollutkaan huumetta – tuomio nurin yle.fi. 18.8.2016. Viitattu 21.11.2020.